UK's NICE Backs Funding For Olympus Plasma System For BPH
The bipolar electrosurgery Plasma system reduces the risks associated with conventual monopolar transurethral resection of the prostate and works out cheaper, according to health technology assessment body NICE.
You may also be interested in...
The UK’s NICE has recommended the use of Boston Scientific’s Rezum system for treatment of enlarged prostate. The minimally invasive procedure involves injecting steam to destroy excess prostate tissue.
An advanced immunotherapy for recurrent glioblastoma and the first biosimilar version of Lucentis for age-related macular degeneration have also been submitted for review by the European Medicines Agency for potential pan-EU authorization.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.